The most popular stories and special reports in FierceBiotech Research, FiercePharmaManufacturing, and the rest of our Life Sciences publications

We hope you've found this year's roundup of the most popular content on the web interesting. Below, you'll find the top-visited stories, slideshows and special reports from each of our weekly and semi-weekly publications this year. The content is listed by popularity in descending order.

We'll be back on Monday with our regular coverage. Enjoy the leftovers.

Suggested Articles

Astellas will develop Frequency's hearing loss drug outside the U.S. in exchange for $80 million upfront and the promise of $545 million down the line.

Inovio Pharmaceuticals is cutting 28% of its workforce and swinging the ax to a bladder cancer test.

The agency was less likely to go against a recommendation when the panellists were united in their opinion.